Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB/RIF results: a prospective observational study in Rwanda

Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB/RIF results: a prospective observational study in Rwanda

Yes === Background: The Xpert MTB/RIF (Xpert) assay is used globally to rapidly diagnose tuberculosis and resistance to rifampicin. We investigated the frequency and predictors of false-positive findings of rifampicin resistance with Xpert. Methods: We did a prospective, observational study of indiv...

Full description

Bibliographic Details
Main Authors: Ngabonziza, J.C.S., Decroo, T., Migambi, P., Habimana, Y.M., Van Duen, A., Meehan, Conor J., Torrea, G., Massou, F., de Rijk, W.B., Ushizimpumu, B., Niyigena, E.B., Ivan, E., Semahore, J.M., Mazarati, J.B., Merle, C.S., Supply, P., Affolabi, D., Rigouts, L., de Jong, B.C.
Language:en
Published: 2021
Subjects:
Xpert MTB/RIF (Xpert) assay
Tuberculosis
Rifampicin
Resistance
Rwanda
Online Access:http://hdl.handle.net/10454/18533

Internet

http://hdl.handle.net/10454/18533

Similar Items